Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

GFP transgenic mice help study cell origins in skin grafts.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Smaller particle sizes of Tetrastigma hemsleyanum powders improve their effectiveness and liver health benefits.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Tideglusib with hydrogel improves wound healing in rats.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

The gel with icariin speeds up wound healing, reduces scarring, and helps hair growth by controlling BMP4 signaling. It also reduces inflammation and improves wound quality in mice, adapts to different wound shapes, and gradually releases icariin to aid healing. It also prevents too much collagen and myofibroblast formation during skin healing.

A man had two rare autoimmune diseases that might be connected.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Indigofera tinctoria leaf extract has many compounds that support its traditional medicinal uses.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

TS-13 speeds up hair regrowth after chemotherapy without affecting treatment effectiveness.

Par3–mInsc and Gαi3 work together to ensure proper cell division orientation in skin development.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Isoalantolactone promotes hair growth by activating specific cell pathways.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.